Arax Advisory Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Arax Advisory Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	4,288 +2,276	+113%	+$499K	0.01%	1199
2026 Q1	$397K	Buy	2,012 +1,034	+106%	+$181K	0.01%	741
2025 Q4	$166K	Sell	978 -429	-30%	-$65.8K	﹤0.01%	1120
2025 Q3	$185K	Buy	1,407 +1,061	+307%	+$127K	﹤0.01%	1293
2025 Q2	$36.7K	Buy	346 +32	+10%	+$3.48K	﹤0.01%	1378
2025 Q1	$39K	Buy	314 +18	+6%	+$2.35K	﹤0.01%	1045
2024 Q4	$36.5K	Buy	296 +13	+5%	+$1.53K	﹤0.01%	991
2024 Q3	$31.5K	Buy	283 +212	+299%	+$23.2K	﹤0.01%	900
2024 Q2	$7.58K	Buy	71 +1	+1%	+$110	﹤0.01%	1399
2024 Q1	$8.43K	Hold	70	–	–	﹤0.01%	806
2023 Q4	$8.61K	Hold	70	–	–	﹤0.01%	782
2023 Q3	$9.06K	Hold	70	–	–	﹤0.01%	743
2023 Q2	$8.68K	Hold	70	–	–	﹤0.01%	737
2023 Q1	$10.2K	Hold	70	–	–	﹤0.01%	683
2022 Q4	$11.2K	Hold	70	–	–	﹤0.01%	637
2022 Q3	$9K	Hold	70	–	–	﹤0.01%	681
2022 Q2	$11K	Hold	70	–	–	﹤0.01%	645
2022 Q1	$11K	Hold	70	–	–	﹤0.01%	645
2021 Q4	$9K	Hold	70	–	–	﹤0.01%	683
2021 Q3	$9K	Buy	+70	New	+$10.6K	﹤0.01%	658
2020 Q4	$1K	Sell	6 -2	-25%	-$298	﹤0.01%	704
2020 Q3	$1K	Hold	8	–	–	﹤0.01%	663
2020 Q2	$1K	Hold	8	–	–	﹤0.01%	652
2020 Q1	$1K	Hold	8	–	–	﹤0.01%	649
2019 Q4	$1K	Hold	8	–	–	﹤0.01%	566
2019 Q3	$1K	Hold	8	–	–	﹤0.01%	568
2019 Q2	$1K	Buy	+8	New	+$1.07K	﹤0.01%	575
2018 Q4	$1K	Hold	8	–	–	﹤0.01%	543
2018 Q3	$1K	Buy	+8	New	+$1.38K	﹤0.01%	601

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Arax Advisory Partners's JAZZ Position: Q2 2026 in Review

Arax Advisory Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 113% in Q2 2026, buying an estimated $499K and bringing the position to 4,288 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #1199.

Arax Advisory Partners first reported a position in JAZZ in Q3 2018 and has held it in 29 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Arax Advisory Partners held 4,288 shares of Jazz Pharmaceuticals worth $1.03M as of Q2 2026.
Arax Advisory Partners bought 2,276 Jazz Pharmaceuticals shares in Q2 2026, an estimated $499K.
Jazz Pharmaceuticals made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1199 holding.
Arax Advisory Partners first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 29 quarters since.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.